Other studies have noted that osteoporosis and AD exhibit reduced glucose metabolism in the bone and brain prior to disease onset and that the cellular energy supply is compromised through the impaired effects of AKT on glucose uptake (Fehsel and Christl, 2022). The gene discussed is AKT1; the disease is Alzheimer disease.